Peptides Codex
Home
Incretin

GIP

GIP (glucose-dependent insulinotropic polypeptide) is a 42-amino-acid incretin hormone released from intestinal K-cells after meals, where it helps stimulate glucose-dependent insulin secretion. Long overshadowed by GLP-1, its receptor is now a deliberate target in dual-agonist peptides such as tirzepatide.

By The Peptides Codex Editorial TeamReviewed July 10, 2026
Length
42 aa
Class
Incretin
Function
Incretin hormone that stimulates insulin secretion after eating
Context
Endogenous hormone; one of the two receptors targeted by dual agonists like tirzepatide

The 'other incretin' — the GIP receptor is the second half of GIP/GLP-1 dual agonists.

Also known as: glucose-dependent insulinotropic polypeptide · gastric inhibitory polypeptide

Part of the Metabolic & GLP-1 peptides cluster

Overview

GIP (glucose-dependent insulinotropic polypeptide) is a 42-amino-acid incretin hormone released from intestinal K-cells after meals, where it helps stimulate glucose-dependent insulin secretion. Long overshadowed by GLP-1, its receptor is now a deliberate target in dual-agonist peptides such as tirzepatide.

Source & context

Biological / chemical source: Intestinal K-cells

Primary research or clinical context: Endogenous hormone; one of the two receptors targeted by dual agonists like tirzepatide

Incretin biology

GIP and GLP-1 are the two classical incretins: gut hormones that amplify insulin release specifically when glucose is present. GIP is secreted by K-cells in the upper small intestine, while GLP-1 comes from L-cells further down. Together they explain why oral glucose triggers more insulin than the same glucose given intravenously.

From overlooked to central

For years GIP received far less attention than GLP-1. The success of GIP/GLP-1 dual agonists renewed interest in its receptor pharmacology, and GIP biology is now a core topic in metabolic peptide education. This page describes that physiology; it does not offer treatment guidance.

Sequence

One-letter sequence commonly cited for GIP (educational; isoforms and modifications may differ):

YAEGTFISDYSIAMDKIHQQDFVNWLLAQKGKKNDWKHNITQ

YAEGTFISDYSIAMDKIHQQDFVNWLLAQKGKKNDWKHNITQ

Y1A2E3G4T5F6I7S8D9Y10S11I12A13M14D15K16I17H18Q19Q20D21F22V23N24W25L26L27A28Q29K30G31K32K33N34D35W36K37H38N39I40T41Q42
Helical wheel projection

Residues plotted ~100° apart around an α-helix — clustering of one color reveals an amphipathic face.

Analyze sequences in the playground →

FAQ about GIP

What is GIP?+

GIP (glucose-dependent insulinotropic polypeptide) is a 42-amino-acid incretin hormone released from intestinal K-cells after meals, where it helps stimulate glucose-dependent insulin secretion. Long overshadowed by GLP-1, its receptor is now a deliberate target in dual-agonist peptides such as tirzepatide.

Is GIP an approved medicine?+

GIP is discussed here as a research / educational topic. Endogenous hormone; one of the two receptors targeted by dual agonists like tirzepatide. This is not medical advice.

What is the typical length of GIP?+

GIP is commonly described as approximately 42 amino acids (Incretin).

Related peptides

References & further reading

  1. 1.Wikipedia — Gastric inhibitory polypeptide (GIP)
  2. 2.UniProt — GIP, Gastric inhibitory polypeptide, human (P09681)
Disclaimer: Educational content only. Not medical advice. Not instructions for human use. Research peptides and unapproved products may be restricted or illegal to market for human consumption in your jurisdiction. Consult qualified professionals and applicable law.
You might also like: All peptides · Atlas · Research · Tools
Cite this: Peptides Codex — GIP educational profile.
Tip: Use browser print (Ctrl/Cmd + P) for a clean PDF of this page.